|
Amifostine |
|---|---|
| Trade Name | Ethyol |
| Orphan Indication | For use as a chemoprotective agent for cyclophosphamide in the treatment of advanced ovarian carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 1990-05-30 00:00:00 |
| Sponsor | Clinigen Group plc;Pitcairn House, Crown Square, DE14 2WW; |
